niacin and probucol

niacin has been researched along with probucol in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	23 (44.23)	18.7374
1990's	21 (40.38)	18.2507
2000's	3 (5.77)	29.6817
2010's	4 (7.69)	24.3611
2020's	1 (1.92)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Grundy, SM	3
Cramb, R; Florkowski, CM	1
Dalmau Serra, J	1
Vogt, HB	1
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK	1
Hunninghake, DB	4
Blomhoff, JP; Ose, L; Torsvik, H	1
Naito, HK	1
Cohen, L; Morgan, J	1
Davignon, J	1
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Perry, RS	1
Havel, RJ; Kane, JP	1
Malinow, MR	1
Gotto, AM; Jones, PH; Scott, LW	1
Levy, RI; Schaefer, EJ	1
Atmeh, RF; Packard, CJ; Shepherd, J	1
Nash, DT	1
Glueck, CJ	1
Kane, JP; Malloy, MJ	1
Azarnoff, DL; Saunders, RN	1
Gotto, AM; Yeshurun, D	1
Farmer, JA; Gotto, AM	2
Kuo, PT	1
Cziraky, MJ; Spinler, SA	1
Feher, MD; Knight, BL; Lant, AF; Mayne, PD; Patel, DD; Soutar, AK; Webb, JC	1
Auwerx, J; Fruchart, JC; Staels, B; Van Tol, A	1
Beil, FU; Greten, H; Mann, WA; Windler, E	1
Dujovne, CA	1
Bays, HE; Dujovne, CA	1
Chin-Dusting, JP; Shaw, JA	1
Matsushima, T; Ogaki, S	1
Matsuzawa, Y; Nagai, Y; Takemura, K; Yamashita, S; Yanagi, K	1
Veryard, C	1
Chen, L; Chen, SC; Tsui, L; Wu, SJ; Xie, W; Xu, S; Ye, P	1

Reviews

27 review(s) available for niacin and probucol

Article	Year
Cholesterol-lowering drugs as cardioprotective agents. The American journal of cardiology, 1992, Dec-21, Volume: 70, Issue:21 Topics: Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol	1992
Approaches to the management of hypercholesterolaemia. Journal of clinical pharmacy and therapeutics, 1992, Volume: 17, Issue:2 Topics: Bezafibrate; Bile Acids and Salts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1992
Hyperlipoproteinemias: part IV. Drug regimens. South Dakota journal of medicine, 1991, Volume: 44, Issue:5 Topics: Anticholesteremic Agents; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Niacin; Probucol	1991
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity	1990
Management of hyperlipidemia of kidney disease. Kidney international, 1990, Volume: 37, Issue:3 Topics: Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Kidney Failure, Chronic; Kidney Transplantation; Nephrotic Syndrome; Niacin; Probucol	1990
Drug therapy in dyslipidemia. Scandinavian journal of clinical and laboratory investigation. Supplementum, 1990, Volume: 199 Topics: Anticholesteremic Agents; Bile Acids and Salts; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk Factors	1990
Drug treatment of dyslipoproteinemia. Endocrinology and metabolism clinics of North America, 1990, Volume: 19, Issue:2 Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipoproteinemias; Niacin; Probucol	1990
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Contemporary recommendations for evaluating and treating hyperlipidemia. Clinical pharmacy, 1986, Volume: 5, Issue:2 Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol	1986
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pathogenesis and management of lipoprotein disorders. The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20 Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease	1985
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation, 1984, Volume: 69, Issue:5 Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lactation; Lipoproteins; Lovastatin; Naphthalenes; Niacin; Pentanoic Acids; Pregnancy; Pregnancy Complications; Probucol; Tangier Disease; Triglycerides	1984
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Annals of internal medicine, 1982, Volume: 96, Issue:4 Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Niacin; Nicotinic Acids; Phenols; Polyamines; Probucol	1982
Treatment of hypercholesterolemia. The Medical clinics of North America, 1982, Volume: 66, Issue:2 Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine	1982
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Hyperlipidemia: perspectives in diagnosis and treatment. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk; Triglycerides	1995
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety, 1994, Volume: 11, Issue:5 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1994
Dyslipidemia and coronary artery disease. Clinical cardiology, 1994, Volume: 17, Issue:10 Topics: Arteriosclerosis; Cholesterol; Coronary Disease; Drug Therapy, Combination; Exercise; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol	1994
Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:3 Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins, LDL; Liver; Niacin; Niceritrol; Probucol; Randomized Controlled Trials as Topic	1994
Currently available hypolipidaemic drugs and future therapeutic developments. Bailliere's clinical endocrinology and metabolism, 1995, Volume: 9, Issue:4 Topics: Anticholesteremic Agents; Bile Acids and Salts; Cardiology; Clinical Trials as Topic; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1995
Trials of the effects of drugs and hormones on lipids and lipoproteins. Current opinion in lipidology, 1995, Volume: 6, Issue:6 Topics: Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Hormones; Human Growth Hormone; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Niacin; Probucol; Thyroid Hormones	1995
New lipid lowering drugs and new effects of old drugs. Current opinion in lipidology, 1997, Volume: 8, Issue:6 Topics: Anticholesteremic Agents; Arteriosclerosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol; Resins, Plant	1997
Drug interactions of lipid-altering drugs. Drug safety, 1998, Volume: 19, Issue:5 Topics: Contraindications; Drug Interactions; Fenofibrate; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol; Resins, Plant	1998
Lipids and atherosclerosis: clinical management of hypercholesterolaemia. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:3 Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Niacin; Nutritional Physiological Phenomena; Probucol	2001
[Nicotinic acid and the derivative]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3 Topics: Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Niacin; Probucol	2001
[Treatment of high blood cholesterol in patients with coronary heart disease]. Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52 Suppl, Issue:Pt 1 Topics: Anion Exchange Resins; Bezafibrate; Clinical Trials as Topic; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin; Probucol; Risk Factors	1994

Trials

2 trial(s) available for niacin and probucol

Article	Year
Cholesterol-lowering drugs as cardioprotective agents. The American journal of cardiology, 1992, Dec-21, Volume: 70, Issue:21 Topics: Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol	1992
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982

Other Studies

25 other study(ies) available for niacin and probucol

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
[Drug therapy of hyperlipoproteinemias]. Anales espanoles de pediatria, 1991, Volume: 35 Suppl 45 Topics: Adolescent; Child; Child, Preschool; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Hyperlipoproteinemias; Hypolipidemic Agents; Niacin; Probucol	1991
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
[Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1989, Mar-10, Volume: 109, Issue:7-8 Topics: Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Norway; Probucol; Resins, Plant	1989
Current and new therapy for hypercholesterolemia. The Journal of the American Osteopathic Association, 1988, Volume: 88, Issue:7 Topics: Anticholesteremic Agents; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol	1988
Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol. The Journal of family practice, 1988, Volume: 26, Issue:2 Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Phenols; Probucol; Retrospective Studies	1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Archives of internal medicine, 1988, Volume: 148, Issue:1 Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors	1988
The pharmacology and therapeutics of lipid-lowering drugs. American pharmacy, 1987, Volume: NS27, Issue:11 Topics: Adult; Bile Acids and Salts; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1987
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Adverse effects of the treatment for hyperlipidemia. Cardiology clinics, 1986, Volume: 4, Issue:1 Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk	1986
Addition to labeling of cholestyramine. FDA drug bulletin, 1985, Volume: 15, Issue:1 Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Drug Labeling; Gemfibrozil; Humans; Hypolipidemic Agents; Niacin; Pentanoic Acids; Probucol; Thyroxine; United States; United States Food and Drug Administration	1985
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. Biochimica et biophysica acta, 1983, Apr-13, Volume: 751, Issue:2 Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins; Female; Humans; Immunochemistry; Lipoproteins, HDL; Niacin; Phenols; Probucol	1983
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Postgraduate medicine, 1983, Volume: 73, Issue:4 Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates	1983
Pharmacologic therapy for the hyperlipidemic patient. The American journal of medicine, 1983, May-23, Volume: 74, Issue:5A Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Niacin; Probucol	1983
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia. Atherosclerosis, 1993, Volume: 103, Issue:2 Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholesterol; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Pedigree; Polymorphism, Genetic; Probucol; Receptors, LDL; Simvastatin	1993
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993
Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Israel journal of medical sciences, 1996, Volume: 32, Issue:6 Topics: Actins; Animals; Apolipoproteins; Cholestyramine Resin; Clofibrate; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Lipoproteins, HDL; Liver; Lovastatin; Male; Niacin; Probucol; Rats; Rats, Wistar; Simvastatin	1996
American Heart Association - Scientific Sessions 2006. Cell therapies for ischemic tissues and treatments for lipid metabolism disorders. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:1 Topics: Animals; Cell- and Tissue-Based Therapy; Cholesterol, LDL; Coronary Disease; Endothelial Cells; Erythropoietin; Extremities; Fibroblast Growth Factor 2; Humans; Ischemia; Lipid Metabolism Disorders; Myocardial Infarction; Niacin; Probucol	2007
Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis. BMJ open, 2023, 05-30, Volume: 13, Issue:5 Topics: Cholestyramine Resin; Drug-Related Side Effects and Adverse Reactions; Fibric Acids; Gemfibrozil; Humans; Hypolipidemic Agents; Niacin; Probucol	2023

chemdatabank.com